Abstract
The small molecule class IIa HDAC inhibitor TMP269 protects against degeneration in in vitro models of Parkinson’s disease
Full Text
Sign-in/Register to access full text options
Published version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have